Form 4: Vigil Neuroscience Director Receives 5,000 Restricted Stock Units

Vigil Neuroscience, Inc. Director Stefan Vitorovic was granted 5,000 Restricted Stock Units (RSUs) on May 22, 2025, as part of the company's incentive plan.

Summary

• Director Stefan Vitorovic of Vigil Neuroscience, Inc. (VIGL) acquired 5,000 shares of Common Stock on May 22, 2025.
• These shares are Restricted Stock Units (RSUs) issued under the Issuer's 2021 Stock Option and Incentive Plan.
• Each RSU represents the contingent right to receive one share of the Issuer's Common Stock.
• The RSUs will vest upon the earlier of May 22, 2026, or the next annual meeting of the Issuer's stockholders.
• Following this transaction, Stefan Vitorovic beneficially owns 5,000 shares directly.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is a positive event as it aligns management's interests with shareholders and is a standard practice for executive compensation, indicating stability in governance.

Positives

• The grant of 5,000 Restricted Stock Units (RSUs) to Director Stefan Vitorovic aligns his interests with those of shareholders, incentivizing long-term performance.
• The RSUs were issued under the company's 2021 Stock Option and Incentive Plan, indicating a structured approach to executive compensation and retention.

Future Outlook

NA

Industry Context

This Form 4 filing details a routine equity compensation grant to a director, which is a standard practice across various industries to align the interests of board members with those of shareholders. It does not provide broader insights into industry trends or competitive landscape.

Related Party Transactions

• The transaction involves the grant of Restricted Stock Units to Stefan Vitorovic, a Director of Vigil Neuroscience, Inc., which is a common form of compensation for board members.

Stakeholder Impact

• Shareholders: The equity grant to a director helps align their interests with those of shareholders, potentially leading to better long-term performance.
• Director: Stefan Vitorovic receives equity compensation, incentivizing his continued service and contribution to the company.

Next Steps

• The 5,000 Restricted Stock Units are scheduled to vest upon the earlier of May 22, 2026, or the next annual meeting of the Issuer's stockholders.

Key Dates

Recommendation

Keywords

Vigil Neuroscience, VIGL, Form 4, SEC filing, Restricted Stock Units, RSUs, Director compensation, Equity grant, Insider transaction, Stefan Vitorovic